Annual Accounts Payable
$1.86 M
-$826.00 K-30.75%
December 31, 2023
Summary
- As of February 10, 2025, FUSN annual accounts payable is $1.86 million, with the most recent change of -$826.00 thousand (-30.75%) on December 31, 2023.
- During the last 3 years, FUSN annual accounts payable has fallen by -$1.54 million (-45.28%).
Performance
FUSN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$2.50 M
+$643.00 K+34.57%
March 31, 2024
Summary
- As of February 10, 2025, FUSN quarterly accounts payable is $2.50 million, with the most recent change of +$643.00 thousand (+34.57%) on March 31, 2024.
- Over the past year, FUSN quarterly accounts payable has increased by +$1.45 million (+136.80%).
Performance
FUSN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FUSN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.8% | +136.8% |
| 3 y3 years | -45.3% | +136.8% |
| 5 y5 years | +432.9% | +136.8% |
FUSN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.8% | at low | -6.8% | -57.8% |
| 5 y | 5-year | -45.3% | -55.4% | -34.2% | -72.6% |
| alltime | all time | -45.3% | -81.2% | -34.2% | -72.6% |
Fusion Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $2.50 M(+34.6%) |
| Dec 2023 | $1.86 M(-30.8%) | $1.86 M(+76.0%) |
| Sep 2023 | - | $1.06 M(-48.7%) |
| Jun 2023 | - | $2.06 M(+8.2%) |
| Mar 2023 | - | $1.90 M(-29.1%) |
| Dec 2022 | $2.69 M(+22.4%) | $2.69 M(+104.9%) |
| Sep 2022 | - | $1.31 M(-15.5%) |
| Jun 2022 | - | $1.55 M(-12.6%) |
| Mar 2022 | - | $1.77 M(-19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.19 M(-35.4%) | $2.19 M(-42.3%) |
| Sep 2021 | - | $3.80 M(+455.2%) |
| Jun 2021 | - | $685.00 K(-32.7%) |
| Mar 2021 | - | $1.02 M(-70.1%) |
| Dec 2020 | $3.40 M(+309.5%) | $3.40 M(+255.5%) |
| Sep 2020 | - | $956.00 K(+36.0%) |
| Jun 2020 | - | $703.00 K(-75.7%) |
| Mar 2020 | - | $2.89 M(+248.2%) |
| Dec 2019 | $830.00 K(+137.8%) | $830.00 K |
| Dec 2018 | $349.00 K | - |
FAQ
- What is Fusion Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual accounts payable year-on-year change?
- What is Fusion Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly accounts payable year-on-year change?
What is Fusion Pharmaceuticals annual accounts payable?
The current annual accounts payable of FUSN is $1.86 M
What is the all time high annual accounts payable for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual accounts payable is $3.40 M
What is Fusion Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, FUSN annual accounts payable has changed by -$826.00 K (-30.75%)
What is Fusion Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of FUSN is $2.50 M
What is the all time high quarterly accounts payable for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly accounts payable is $3.80 M
What is Fusion Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, FUSN quarterly accounts payable has changed by +$1.45 M (+136.80%)